BMRN - Company ID 0001048477
The table below shows BIOMARIN PHARMACEUTICAL INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.31B | $942.84M | $755.13M | $724.53M | $587.28M | $649.16M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $908.21M | $660.53M | $633.70M | $461.32M | $373.40M | $448.35M |
| Inventory | $1.30B | $1.23B | $1.11B | $894.08M | $776.67M | $698.55M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $3.95B |
| $3.23B |
| $2.96B |
| $2.75B |
| $2.27B |
| $2.34B |
| Property, plant & equipment | $952.51M | $1.04B | $1.07B | $1.07B | $1.04B | $1.03B |
| Goodwill | $196.20M | $196.20M | $196.20M | $196.20M | $196.20M | $196.20M |
| Total assets | $7.59B | $6.99B | $6.84B | $6.38B | $6.00B | $5.85B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $759.03M | $606.99M | $1.18B | $588.88M | $539.82M | $492.55M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.51B | $1.33B | $1.89B | $1.77B | $1.73B | $1.74B |
| Retained earnings | $154.21M | -$194.69M | -$621.55M | -$789.20M | -$925.69M | -$861.61M |
| Total equity | $6.09B | $5.66B | $4.95B | $4.60B | $4.27B | $4.11B |